FacultyFaculty/Author Profile

Jennifer L. Chu

Debevoise & Plimpton LLP

New York, NY, USA


Jennifer Chu is a corporate partner and member of the firm's Mergers & Acquisitions and Private Equity Groups. Her practice focuses on advising corporations and private equity firms in mergers and acquisitions, joint ventures and other corporate matters, with a particular focus on transactions in the insurance and healthcare industries. Ms. Chu is recommended by The Legal 500 US (2016), where she is described as "very seasoned in handling private equity matters."

Ms. Chu is a contributing author to the Health Care M ergers and Acquisitions Answer Book (Practising Law Institute, 2016), an extensive reference guide addressing structuring, regulatory, due diligence and documentation issues in healthcare M&A and licensing transactions. Her recent articles include "A Closer Look," Best' s Review (June, 2015).

Ms. Chu joined the firm in 2006. She received her J.D. cum laude from Harvard Law School in 2006, where she served as co-Editor-in-Chief of the Harvard International Law journal. She received her M.A. with distinction from the University of London in 2002, and her A.B. magna cum laude from Harvard College in 2001.

Ms. Chu is a member of the Bar of New York.

JENNIFER L. CHU'S SELECT REPRESENTATIONS

Allergan in its $2.47 billion acquisition of ZELTIQ, a medical technology company focused on utilizing its proprietary CoolSculpting controlled-cooling technology platform, the sales leader in the fast-growing body contouring segment of medical aesthetics .

Allergan in its $2.9 billion acquisition of LifeCell Corporation, a regenerative medicine business.

Stone Point Capital in its investment in Millstein & Co.. a diversified financial services firm that specializes in developing and implementing solutions for complex corporate and public finance problems.

Apollo Global Management in its acquisition of a majority interest inthe asset management business of AR Capital (subsequently withdrawn), its acquisition of the wholesale distribution business ofRCS Capital and its substantial minority equity investment in RCS Capital.

Blackstone Group 's Tactical  Opportunities Group in the acquisition of Philadelphia Financial Group from Tiptree Financial.

Allergan in its global collaboration agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic.

Lannett in its acquisition for $1.23 billion incash, plus additional contingent consideration, of Kremers Urban Pharmaceuticals, the U.S. specialty generic pharmaceuticals subsidiary of global  biopharmaceuticals company UCB.

New York Life Investments in its acquisition of lndexlQ, a leader inthe liquid alternative exchange-traded fund industry.

Actavis in the sale of Aptalis Pharmaceutical Technologies, a pharmaceutical outsourcing and R&D business in the U.S., to TPG.

Actavis in the sale of its branded respiratory business inthe U.S. and Canada to AstraZeneca for $600 million, and an additional payment of $100 million relatingto certain other agreements.

Clayton, Dubilier & Rice in its acquisition of up to a 49% stake in NYSE-listed CHC Group, the world's largest commercial helicopter operator with an enterprise value of $1.9 billion.

Chemtura in the $1 billion sale of its agrochemicals business, Chemtura AgroSolutions .

Johnson & Johnson inthe sale of its worldwide intimate health business to Reckitt Benckiser, a UK-based consumer goods company.

PSAV, a Kelso & Company portfolio company, in its acquisition by affiliates of Goldman Sachs.

The Special Committee of the Board of Directors of Dell in the $24.9 billion sale of Dellto an investor group including Michael Dell and Silver Lake.

Warner Music Group  in its $765 million acquisition of the Parlophone Label Group from Universal Music Group.

Goldman Sachs Reinsurance Group in its acquisition  ofthe Bermuda-based reinsurance operations of Ariel Holdings

Clayton Dubilier & Rice in its acquisition of a 60% stake in Hussmann International, a leading global manufacturer of refrigerated display merchandizing equipment and refrigeration systems for the retail food industry, from Ingersoll Rand

Cunningham Lindsey in its acquisition of the loss adjusting business of GAB Robins

American International Group in the proposed sale of its Asian life insurance unit, American International Assurance, to Prudential pie for $35.5 billion

Jennifer L. Chu is associated with the following items:
MP3 Audio  MP3 Audio Health Care M&A: Three Hot Topics, Monday, April 03, 2017
Indemnification and Division / Subsidiary Issues in Private Acquisitions or Sales - Indemnification and Division / Subsidiary Issues in Private Acquisitions or Sales, Tuesday, June 27, 2017
Audio Only On-Demand Web  Audio Only On-Demand Web Health Care M&A: Three Hot Topics - Health Care M&A: Three Hot Topics, Friday, April 07, 2017
Transcripts  Transcripts Health Care M&A: Three Hot Topics - Health Care M&A: Three Hot Topics, Friday, April 07, 2017
Indemnification and Division / Subsidiary Issues in Private Acquisitions or Sales - Indemnification and Division / Subsidiary Issues in Private Acquisitions or Sales, Tuesday, June 27, 2017
Web Segment  Web Segment Indemnification and Division / Subsidiary Issues in Private Acquisitions or Sales - Acquiring or Selling the Privately Held Company 2017, Tuesday, June 27, 2017
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Indemnification and Division / Subsidiary Issues in Private Acquisitions or Sales - Indemnification and Division / Subsidiary Issues in Private Acquisitions or Sales, Tuesday, June 27, 2017
On-Demand Web Programs  On-Demand Web Programs Acquiring or Selling the Privately Held Company 2017, Tuesday, July 18, 2017, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.